Actio Biosciences News and Activities

Acquisition, funding and merger involving Actio Biosciences.

• Actio Biosciences has just announced a $66 Million fundraising (posted on June 19 2025).

View the org chart displaying its 18 main executives

Most searched biographies at Actio Biosciences

• David Goldstein, Chief Executive Officer
• Basheer Zada, Director
• Emil Kakkis, Director

Create your alert
to follow the executive moves at Actio Biosciences.

Actio Biosciences has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Actio Biosciences

• Press Releases Archives • Page 5 of 5 • Actio Biosciences
• Press Releases Archives • Page 4 of 4 • Actio Biosciences

Social media about Actio Biosciences

• Actio Biosciences on Wikipedia, Google News & Yahoo Finance
• Actio Biosciences on LinkedIn, X (Twitter) & YouTube